On Invalid Date, T2 Biosystems (NASDAQ: TTOO) reported Q4 2023 earnings per share (EPS) of $2.60, up 118.61% year over year. Total T2 Biosystems earnings for the quarter were -$10.34 million. In the same quarter last year, T2 Biosystems's earnings per share (EPS) was -$13.97.
As of Q2 2024, T2 Biosystems's earnings has grown year over year. T2 Biosystems's earnings in the past year totalled -$50.08 million.
What is TTOO's earnings date?
T2 Biosystems's earnings date is Invalid Date. Add TTOO to your watchlist to be reminded of TTOO's next earnings announcement.
What was TTOO's revenue last quarter?
On Invalid Date, T2 Biosystems (NASDAQ: TTOO) reported Q4 2023 revenue of $1.68 million up 69.38% year over year. In the same quarter last year, T2 Biosystems's revenue was $5.48 million.
What was TTOO's revenue growth in the past year?
As of Q2 2024, T2 Biosystems's revenue has grown -67.75% year over year. This is 68.14 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.38%. T2 Biosystems's revenue in the past year totalled $7.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.